Other OTC - Delayed Quote • USD
RepliCel Life Sciences Inc. (REPCF)
At close: March 15 at 11:20 AM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
353.7350
353.7350
353.7350
353.7350
Operating Expense
1,818.1410
1,746.4280
2,652.2240
1,682.0020
Operating Income
-1,464.4060
-1,392.6930
-2,298.4890
-1,328.2670
Net Non Operating Interest Income Expense
-1.0780
-6.6580
-5.4590
0.3580
Other Income Expense
1,396.1950
656.1230
-1,769.3670
-252.3760
Pretax Income
-69.2890
-743.2280
-4,073.3150
-1,580.2850
Net Income Common Stockholders
-69.2870
-743.2280
-4,073.3150
-1,580.2850
Diluted NI Available to Com Stockholders
-69.2870
-743.2280
-4,073.3150
-1,580.2850
Basic EPS
-0.02
-0.02
-0.13
-0.06
Diluted EPS
-0.02
-0.02
-0.13
-0.06
Basic Average Shares
46,234.4520
37,767.6200
32,486.7700
26,961.0670
Diluted Average Shares
46,234.4520
37,767.6200
32,486.7700
26,961.0670
Total Expenses
1,818.1410
1,746.4280
2,652.2240
1,682.0020
Interest Income
0.7250
0.0430
0.0690
0.3580
Interest Expense
1.8030
6.7010
5.5280
--
Net Interest Income
-1.0780
-6.6580
-5.4590
0.3580
Net Income from Continuing & Discontinued Operation
-69.2870
-743.2280
-4,073.3150
-1,580.2850
Normalized Income
630.1810
-198.1380
-3,177.3670
-1,396.3950
EBIT
-67.4860
-736.5270
-4,067.7870
-1,580.2850
EBITDA
-66.0750
-735.6880
-4,066.6390
-1,578.7110
Reconciled Depreciation
1.4110
0.8390
1.1480
1.5740
Net Income from Continuing Operation Net Minority Interest
-69.2870
-743.2280
-4,073.3150
-1,580.2850
Total Unusual Items Excluding Goodwill
-699.4680
-545.0900
-895.9480
-183.8900
Total Unusual Items
-699.4680
-545.0900
-895.9480
-183.8900
Normalized EBITDA
633.3930
-190.5980
-3,170.6910
-1,394.8210
12/31/2020 - 5/3/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade